Pinsalab has been acquired by Deutsche Invest Capital Solutions
The private shareholders of Pinsalab S.r.l. have sold the company to Deutsche Invest Capital Solutions GmbH.
Pinsalab supplies pinsas to large retailers and Horeca operators in Italy and in a number of other European countries. Pinsa, also known as Roman pizza, is an ancient recipe that has become popular in Italy over the past two or three years. The company markets its product under the Pinsami and Mr. Pinsa labels in room temperature, chilled, and frozen formats. Pinsalab started its activity a few years ago and was one of the market’s first movers. The company is now the leader of one of the fastest-growing segments, increasing by 50% annually in Italy, as consumers are looking for a healthier alternative to pizza. Pinsa producers compete with frozen pizza and pizza-base companies. They are all part of the savory bakery market.
Deutsche Invest Capital Solutions, a member of the Deutsche Invest Capital Partners group, specializes in leveraged buy-outs, growth investments and carveouts of family businesses in Europe, with a focus on the DACH region. Deutsche Invest Capital Solutions follows a sustainable, long-term investment approach which combines transaction, finance, value-creating management and operational know-how.
Oaklins’ team in Italy acted as the exclusive financial advisor for the sellers in this transaction.
Claudio Campani, Gianluca Ghiaroni, and Cristian Lin
Shareholders, Pinsalab S.r.l.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more